BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bosch OG, Esposito F, Havranek MM, Dornbierer D, von Rotz R, Staempfli P, Quednow BB, Seifritz E. Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans. Neuropsychopharmacology 2017;42:2141-51. [PMID: 28561068 DOI: 10.1038/npp.2017.110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Rodriguez-Cruz V, Morris ME. γ-Hydroxybutyric Acid-Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 Inhibitors. J Pharmacol Exp Ther 2021;378:42-50. [PMID: 33963018 DOI: 10.1124/jpet.121.000566] [Reference Citation Analysis]
2 Raposo Pereira F, Zhutovsky P, Mcmaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA. Recreational use of GHB is associated with alterations of resting state functional connectivity of the central executive and default mode networks. Hum Brain Mapp 2019;40:2413-21. [PMID: 30720906 DOI: 10.1002/hbm.24532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Raposo Pereira F, McMaster MTB, de Vries YDAT, Polderman N, van den Brink W, van Wingen GA. Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network. Eur Addict Res 2019;25:173-81. [PMID: 30999293 DOI: 10.1159/000497381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Dornbierer DA, Kometer M, Von Rotz R, Studerus E, Gertsch J, Gachet MS, Vollenweider FX, Seifritz E, Bosch OG, Quednow BB. Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring. Eur Neuropsychopharmacol 2019;29:539-48. [PMID: 30824339 DOI: 10.1016/j.euroneuro.2019.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Cai H, Xu X, Zhang Y, Cong X, Lu X, Huo X. Elevated lead levels from e-waste exposure are linked to sensory integration difficulties in preschool children. NeuroToxicology 2019;71:150-8. [DOI: 10.1016/j.neuro.2019.01.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
6 Sinenchenko AG, Lodyagin AN, Batotsyrenov BV, Gluchkov SI. [The delirium sindrome in a patient with acute poisoning by 1,4-butanediol]. Zh Nevrol Psikhiatr Im S S Korsakova 2018;118:53-6. [PMID: 30698562 DOI: 10.17116/jnevro201811812153] [Reference Citation Analysis]
7 Bosch OG, Esposito F, Dornbierer D, von Rotz R, Kraehenmann R, Staempfli P, Quednow BB, Seifritz E. Prohedonic properties of gamma-hydroxybutyrate are associated with changes in limbic resting-state functional connectivity. Hum Psychopharmacol 2018;33:e2679. [PMID: 30426556 DOI: 10.1002/hup.2679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Raposo Pereira F, McMaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA. Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans. Neuroimage Clin 2018;20:923-30. [PMID: 30308378 DOI: 10.1016/j.nicl.2018.09.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Raposo Pereira F, Mcmaster MT, Polderman N, de Vries YD, van den Brink W, van Wingen GA. Adverse effects of GHB-induced coma on long-term memory and related brain function. Drug and Alcohol Dependence 2018;190:29-36. [DOI: 10.1016/j.drugalcdep.2018.05.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
10 Bosch OG, Esposito F, Dornbierer D, Havranek MM, von Rotz R, Kometer M, Staempfli P, Quednow BB, Seifritz E. Gamma-hydroxybutyrate increases brain resting-state functional connectivity of the salience network and dorsal nexus in humans. Neuroimage 2018;173:448-59. [PMID: 29524621 DOI: 10.1016/j.neuroimage.2018.03.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jacobson LH, Vlachou S, Slattery DA, Li X, Cryan JF. The Gamma-Aminobutyric Acid B Receptor in Depression and Reward. Biol Psychiatry 2018;83:963-76. [PMID: 29759132 DOI: 10.1016/j.biopsych.2018.02.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
12 Mamelak M. Parkinson's Disease, the Dopaminergic Neuron and Gammahydroxybutyrate. Neurol Ther 2018;7:5-11. [PMID: 29368093 DOI: 10.1007/s40120-018-0091-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
13 Hernandez-Garcia L, Lahiri A, Schollenberger J. Recent progress in ASL. Neuroimage 2019;187:3-16. [PMID: 29305164 DOI: 10.1016/j.neuroimage.2017.12.095] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
14 Hassan Z, Bosch OG, Singh D, Narayanan S, Kasinather BV, Seifritz E, Kornhuber J, Quednow BB, Müller CP. Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Front Psychiatry 2017;8:152. [PMID: 28868040 DOI: 10.3389/fpsyt.2017.00152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]